May 2011 Editor's Picks: Products from David Round Company and Globe Medical Tech - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

May 2011 Editor's Picks: Products from David Round Company and Globe Medical Tech

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

product David Round Company
Lift tables incorporate protected hydraulic packages

The David Round Company’s 304 stainless-steel lift tables are designed for bulk-material applications in controlled pharmaceutical manufacturing environments (e.g., cleanrooms). The machines’ hydraulic packages are laid out flat on the bottom of the tables, and the cylinders are in a horizontal position. This design enables the hydraulic components to be covered, thus protecting them and reducing opportunities for contamination.

Personnel can operate the tables’ hydraulic packages with pushbutton controls. The tables can be raised from 18 in. to as high as 42 in., which is within the appropriate ergonomic range. The tables’ reinforced scissors-type lift capacity is rated at 2000 lb.

The tables are mounted on wheels for portability, and personnel can collapse them to the floor. In addition, the tables’ highly polished finish, smooth welds, and few crevices enable easy wash down.


productGlobe Medical Tech
Prefilled syringes enhance safety

Globe Medical Tech’s dual- and single-chamber prefilled syringes are designed to enhance safety. The syringes’ integrated needle-stick prevention feature and vacuum needle autoretraction technology provide full compliance with US and European safety regulations. After injection, the needle is retracted into the syringe body with a gentle push on the plunger. The syringe does not need any activation (e.g., twisting or capping) to engage the safety and contains no springs or metal components.

In combination with material and lubricant selections, the single- and dual-chamber syringes help maximize pharmaceutical compatibility. The dual-chamber syringe maintains the pharmaceutical components in separate chambers, thus extending the shelf life of some drugs. The syringes are made with medical-grade plastics that comply with FDA and international pharmacopoeial regulations. The plastics are compatible with a wide range of pharmaceutical drugs, and the components offer biocompatibility and low leachability. The syringes are designed to reduce dosing errors and contamination.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Equipment and Processing Report,
Click here